The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
Named after the Japanese word for satisfied, Manzoku is your daily support for feeling nourished, grounded, and in control
The poorer total and cell surface expressions observed with GIP/GLP-1R would be expected to impair agonist-induced endocytosis
These foundations support your skins natural resilience and can significantly improve mild laxity
To achieve blood levels of at least 30 ng/mL, adults living at temperate latitudes (think: anywhere with distinct seasons) need 800 to 1,000 IU per day, ideally from vitamin D3, which is more effective than D2
Formulated with high-potency plant-based enzymes, it supports the optimal breakdown of the foods you eat